{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:07:07Z","timestamp":1784696827284,"version":"3.55.0"},"reference-count":28,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Angiology"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    The present study evaluated the long-term prognostic impact of comorbid peripheral artery disease (PAD) in non-ST-elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI). We analyzed data from 1245 NSTEMI patients who underwent PCI between 2013 and 2022. PAD was identified from electronic health records based on an ankle-brachial index &lt;0.9 or prior lower extremity revascularization. The primary outcome was major adverse cardiovascular events (MACE), including all-cause mortality, recurrent myocardial infarction, stroke, and heart failure hospitalization (mean follow-up: 8.2\u2009years). Kaplan-Meier survival analysis and Cox proportional hazards regression were adjusted for age, gender, diabetes, hypertension, and creatinine levels. Of 1245 patients, 312 (25.1%) had PAD and were older (68.4\u2009\u00b1\u20099.2 vs 62.7\u2009\u00b1\u200910.1\u2009years,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001) and had higher rates of diabetes (48% vs 32%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.002) and hypertension (76% vs 61%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.01). MACE occurred in 42.3% of PAD patients versus 25.6% in those without PAD (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001). Kaplan-Meier analysis showed reduced MACE-free survival in PAD patients (log-rank\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001). Cox regression confirmed PAD as an independent predictor of MACE (hazard ratio: 1.78, 95% CI 1.45-2.19,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009&lt;\u2009.001). In NSTEMI patients post-PCI, PAD significantly increased long-term MACE risk, replicating worse outcomes observed in polyvascular disease and underscoring the need for enhanced risk stratification of this cohort.\n                  <\/jats:p>","DOI":"10.1177\/00033197251382399","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T06:32:50Z","timestamp":1761373970000},"page":"1062-1067","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Long-Term Cardiovascular Outcomes in Patients With NSTEMI Undergoing Percutaneous Coronary Intervention: Impact of Comorbid Peripheral Artery Disease"],"prefix":"10.1177","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4085-8151","authenticated-orcid":false,"given":"\u00c7a\u011fr\u0131","family":"Zorlu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u011fmur","family":"Demirezen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay\u0131han","family":"Karaman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Karayakali","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ata\u00e7","family":"\u00c7elik","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokat Gaziosmanpasa University Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.30960"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318535"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2023.06.005"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.303849"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001005"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8295054"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312864"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000084586"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2018.04.005"},{"key":"e_1_3_2_11_2","first-page":"470","article-title":"Impact of peripheral arterial disease on outcomes of acute coronary syndrome","volume":"19","author":"Gherasie FA","year":"2024","unstructured":"Gherasie FA, Popescu MR, Bartos D. Impact of peripheral arterial disease on outcomes of acute coronary syndrome. Maedica (Bucur). 2024;19:470-477.","journal-title":"Maedica (Bucur)"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.11.005"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu080"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2022.04.054"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2020.11.001"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuad107"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009871"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318276fbcb"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2023.06.003"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2020.05.014"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14030251"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00663-9"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/0003319710371620"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae557"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.4274\/ijca.2024.18291"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.02.014"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn471"},{"key":"e_1_3_2_28_2","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman MD","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, et al 2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726-e779.","journal-title":"Circulation"},{"key":"e_1_3_2_29_2","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran R","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, et al A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393-1399.","journal-title":"J Am Coll Cardiol"}],"container-title":["Angiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00033197251382399","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00033197251382399","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00033197251382399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:49:31Z","timestamp":1784695771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00033197251382399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/00033197251382399"],"URL":"https:\/\/doi.org\/10.1177\/00033197251382399","relation":{},"ISSN":["0003-3197","1940-1574"],"issn-type":[{"value":"0003-3197","type":"print"},{"value":"1940-1574","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}